TXMD - TherapeuticsMD Inc
IEX Last Trade
1.91
0.030 1.571%
Share volume: 5,267
Last Updated: Fri 30 Aug 2024 07:45:47 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.88
0.03
1.60%
Summary score
23%
Profitability
23%
Dept financing
24%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 31-Dec-2019 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
45.33%
Return on assets
-7.67%
Return on sales
200.44%
Return on invested capital
54.94%
Total debt ratio
111.98%
Debt ratio change over timeo
-0.59%
Current Ratio
1.69%
Quick Ratio
1.61%
Cash Position Ratio
1.12%
Short-term ratios 31-Dec-2022 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.51%
Return on assets
-4.08%
Return on sales
-521.86%
Return on invested capital
-14.31%
Total debt ratio
41.25%
Debt ratio change over timeo
-5.22%
Current Ratio
1.39%
Quick Ratio
1.39%
Cash Position Ratio
0.79%
Last quarter ratios 31-Dec-2023
The data are presented for the financials results of the last quarter.
Return on equity
-3.01%
Return on assets
-3.72%
Return on sales
-358.8%
Return on invested capital
-3.58%
Total debt ratio
32.38%
Debt ratio change over time
-10.04%
Current Ratio
1.72%
Quick Ratio
1.72%
Cash Position Ratio
0.63%
Performance ratios (change over 4 years) 31-Dec-2019 - 31-Dec-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-6.17%
Return on assets
-106.37%
Return on sales
859.04%
Return on invested capital
-15.72%
Total debt ratio
-59.19%
Debt ratio change over time
-0.59%
Current Ratio
-4.94%
Quick Ratio
-4.97%
Cash Position Ratio
-2.81%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TXMD | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 45.33% | 20.69% | 17.34% | 7.9% |
| Return on assets | -7.67% | 4.16% | 8.21% | 3.23% |
| Return on sales | 200.44% | 28.16% | 41.18% | 25.36% |
| Return on invested capital | 54.94% | 9.72% | -219.55% | 7.62% |
| Profitability | 75% | 32% | 40% | 21% |
| Total debt ratio | 111.98% | 83.67% | 55.88% | 60.1% |
| Debt ratio change over time | -0.59% | -4.1% | -0.73% | -33.57% |
| Dept financing | 50% | 19% | 12% | 13% |
| Current Ratio | 1.39% | 1.1% | 0% | 1.14% |
| Quick Ratio | 1.39% | 0.86% | 0% | 0.9% |
| Cash Position Ratio | 0.79% | 0.15% | 0% | 0.49% |
| Liquididy | 75% | 37% | 37% | 48% |
| Short-term ratios | TXMD | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -8.51% | 11.94% | 0% | 12.29% |
| Return on assets | -4.08% | 4.45% | 0% | 3.02% |
| Return on sales | -521.86% | 29.67% | 0% | 25.18% |
| Return on invested capital | -14.31% | 9.96% | 0% | 12.71% |
| Profitability | 0% | 94% | 0% | 88% |
| Total debt ratio | 41.25% | 80.64% | 0% | 60.17% |
| Debt ratio change over time | -5.22% | -40.42% | 0% | -162.47% |
| Dept financing | 13% | 25% | 25% | 19% |
| Current Ratio | 1.39% | 1.1% | 0% | 1.14% |
| Quick Ratio | 1.39% | 0.86% | 0% | 0.9% |
| Cash Position Ratio | 0.79% | 0.15% | 0% | 0.49% |
| Liquididy | 75% | 40% | 0% | 52% |